LYZER DIAGNOSTICS
Boulder · Founded 2007
About LYZER DIAGNOSTICS
It is developing two proprietary testing platforms that will enable healthcare providers and life science researchers to better manage patients, diagnose disease and develop targeted therapeutics and diagnostics. The Rapid Testing (Point-of-Care) technology enables cost-effective management of many of the most common disease states, and completely eliminates the need for any instrumentation and reagents. Single use devices in development include tests for anemia (Hb), coagulation (Coumadin therapy), c-Reactive Protein (CRP), HbA1c and numerous other applications in clinical medicine.
Company Facts
- Founded: 2007
- Operating status: Closed
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Total funding: $1.3M
- Last round: Debt Financing (Jan 2008)
- Website: http://eveiamedical.com
Industries & Categories
Biotechnology, Health Care, Health Diagnostics, Medical Device
Canonical: https://fsome.com/organization/lyzer-diagnostics-2044082 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.